These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
342 related articles for article (PubMed ID: 17890669)
41. Review of the effects of anti-angiogenic compounds on the epiphyseal growth plate. Hall AP; Westwood FR; Wadsworth PF Toxicol Pathol; 2006; 34(2):131-47. PubMed ID: 16537292 [TBL] [Abstract][Full Text] [Related]
42. Targeting tumor micro-environment for design and development of novel anti-angiogenic agents arresting tumor growth. Gacche RN; Meshram RJ Prog Biophys Mol Biol; 2013 Nov; 113(2):333-54. PubMed ID: 24139944 [TBL] [Abstract][Full Text] [Related]
43. Expression and localization of placenta growth factor and PlGF receptors in human meningiomas. Donnini S; Machein MR; Plate KH; Weich HA J Pathol; 1999 Sep; 189(1):66-71. PubMed ID: 10451490 [TBL] [Abstract][Full Text] [Related]
44. Vascular endothelial growth factor is involved in neoangiogenesis in Hirudo medicinalis (Annelida, Hirudinea). Tettamanti G; Grimaldi A; Valvassori R; Rinaldi L; de Eguileor M Cytokine; 2003 Jun; 22(6):168-79. PubMed ID: 12890449 [TBL] [Abstract][Full Text] [Related]
46. A case of mandible hypoplasia treated with autologous bone graft from mandibular symphysis: Expression of VEGF and receptors in bone regeneration. Marini M; Bertolai R; Manetti M; Sgambati E Acta Histochem; 2016 Jul; 118(6):652-656. PubMed ID: 27432807 [TBL] [Abstract][Full Text] [Related]
47. VEGF and VEGF-C: specific induction of angiogenesis and lymphangiogenesis in the differentiated avian chorioallantoic membrane. Oh SJ; Jeltsch MM; Birkenhäger R; McCarthy JE; Weich HA; Christ B; Alitalo K; Wilting J Dev Biol; 1997 Aug; 188(1):96-109. PubMed ID: 9245515 [TBL] [Abstract][Full Text] [Related]
48. Alendronate affects cartilage resorption by regulating vascular endothelial growth factor expression in rats. Kang JH; Choi NK; Kang SJ; Yang SY; Ko HM; Jung JY; Kim MS; Koh JT; Kim WJ; Oh WM; Kim BY; Kim SH Anat Rec (Hoboken); 2010 May; 293(5):786-93. PubMed ID: 20432372 [TBL] [Abstract][Full Text] [Related]
49. Vascular endothelial growth factor (VEGF) receptor-2 antagonists inhibit VEGF- and basic fibroblast growth factor-induced angiogenesis in vivo and in vitro. Tille JC; Wood J; Mandriota SJ; Schnell C; Ferrari S; Mestan J; Zhu Z; Witte L; Pepper MS J Pharmacol Exp Ther; 2001 Dec; 299(3):1073-85. PubMed ID: 11714897 [TBL] [Abstract][Full Text] [Related]
50. Involvement of Flt-1 tyrosine kinase (vascular endothelial growth factor receptor-1) in pathological angiogenesis. Hiratsuka S; Maru Y; Okada A; Seiki M; Noda T; Shibuya M Cancer Res; 2001 Feb; 61(3):1207-13. PubMed ID: 11221852 [TBL] [Abstract][Full Text] [Related]
51. Recombinant bone morphogenetic protein-2 induces up-regulation of vascular endothelial growth factor and interleukin 6 in human pre-osteoblasts: role of reactive oxygen species. Akeel S; El-Awady A; Hussein K; El-Refaey M; Elsalanty M; Sharawy M; Al-Shabrawey M Arch Oral Biol; 2012 May; 57(5):445-52. PubMed ID: 22041018 [TBL] [Abstract][Full Text] [Related]
52. Immunolocalization of vascular endothelial growth factor on intramuscular ectopic osteoinduction by bone morphogenetic protein-2. Kakudo N; Kusumoto K; Wang YB; Iguchi Y; Ogawa Y Life Sci; 2006 Oct; 79(19):1847-55. PubMed ID: 16857215 [TBL] [Abstract][Full Text] [Related]
53. Vascular endothelial growth factor fails to acutely modulate endothelial permeability during early angiogenesis in the chick chorioallantoic membrane. DeFouw LM; DeFouw DO Microvasc Res; 2000 Nov; 60(3):212-21. PubMed ID: 11078637 [TBL] [Abstract][Full Text] [Related]
54. Regulation of multiple angiogenic pathways by Dll4 and Notch in human umbilical vein endothelial cells. Harrington LS; Sainson RC; Williams CK; Taylor JM; Shi W; Li JL; Harris AL Microvasc Res; 2008 Mar; 75(2):144-54. PubMed ID: 17692341 [TBL] [Abstract][Full Text] [Related]
55. An autocrine loop directed by the vascular endothelial growth factor promotes invasiveness of human melanoma cells. Lacal PM; Ruffini F; Pagani E; D'Atri S Int J Oncol; 2005 Dec; 27(6):1625-32. PubMed ID: 16273219 [TBL] [Abstract][Full Text] [Related]
56. Inhibition of vascular endothelial growth factor-associated tyrosine kinase activity with SU5416 blocks sprouting in the microvascular endothelial cell spheroid model of angiogenesis. Haspel HC; Scicli GM; McMahon G; Scicli AG Microvasc Res; 2002 May; 63(3):304-15. PubMed ID: 11969307 [TBL] [Abstract][Full Text] [Related]
57. Chimeric VEGF-E(NZ7)/PlGF promotes angiogenesis via VEGFR-2 without significant enhancement of vascular permeability and inflammation. Zheng Y; Murakami M; Takahashi H; Yamauchi M; Kiba A; Yamaguchi S; Yabana N; Alitalo K; Shibuya M Arterioscler Thromb Vasc Biol; 2006 Sep; 26(9):2019-26. PubMed ID: 16794222 [TBL] [Abstract][Full Text] [Related]
58. Vascular endothelial growth factor family of ligands and receptors: review. Otrock ZK; Makarem JA; Shamseddine AI Blood Cells Mol Dis; 2007; 38(3):258-68. PubMed ID: 17344076 [TBL] [Abstract][Full Text] [Related]
59. Neuropilin-1 regulates attachment in human endothelial cells independently of vascular endothelial growth factor receptor-2. Murga M; Fernandez-Capetillo O; Tosato G Blood; 2005 Mar; 105(5):1992-9. PubMed ID: 15522955 [TBL] [Abstract][Full Text] [Related]
60. VEGF and bone cell signalling: an essential vessel for communication? Clarkin CE; Gerstenfeld LC Cell Biochem Funct; 2013 Jan; 31(1):1-11. PubMed ID: 23129289 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]